ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35049
-0,49%
Bitcoin
66.299,08
0,45%
Brent Oil
82,275
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Organogenesis Holdings Inc (ORGO)

  7. Organogenesis Holdings Inc (ORGO) Notícias

ORGO

Organogenesis (ORGO)

Organogenesis Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ORGO
DataHoraFonteTítuloCódigoCompanhia
06/06/202417:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
09/05/202417:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ORGOOrganogenesis Holdings Inc
09/05/202417:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2024 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
02/05/202408:00GlobeNewswire Inc.Organogenesis Achieves Primary Endpoint in Phase 3 Clinical Trial of ReNu® for Knee OsteoarthritisNASDAQ:ORGOOrganogenesis Holdings Inc
16/04/202408:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
03/04/202408:30GlobeNewswire Inc.Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud CaseNASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202418:31Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202418:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ORGOOrganogenesis Holdings Inc
29/02/202418:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
23/02/202419:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
12/02/202409:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
08/02/202418:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024NASDAQ:ORGOOrganogenesis Holdings Inc
02/02/202411:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ORGOOrganogenesis Holdings Inc
09/01/202418:43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ORGOOrganogenesis Holdings Inc
09/11/202318:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Third Quarter 2023 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
05/10/202308:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2023 Financial Results on November 9, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
28/09/202310:15GlobeNewswire Inc.Organogenesis Applauds Withdrawal of Local Coverage Determinations by Novitas, First Coast Service Options and CGSNASDAQ:ORGOOrganogenesis Holdings Inc
06/09/202317:05GlobeNewswire Inc.Organogenesis Holdings Inc. to Participate in the Morgan Stanley 21st Annual Global Healthcare ConferenceNASDAQ:ORGOOrganogenesis Holdings Inc
09/08/202317:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 GuidanceNASDAQ:ORGOOrganogenesis Holdings Inc
10/07/202308:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202317:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202317:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ORGOOrganogenesis Holdings Inc
10/05/202317:05GlobeNewswire Inc.Organogenesis Holdings Inc. Reports First Quarter 2023 Financial ResultsNASDAQ:ORGOOrganogenesis Holdings Inc
01/05/202317:13Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ORGOOrganogenesis Holdings Inc
01/05/202317:10Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ORGOOrganogenesis Holdings Inc
27/04/202308:30GlobeNewswire Inc.Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of DirectorsNASDAQ:ORGOOrganogenesis Holdings Inc
14/04/202319:28Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ORGOOrganogenesis Holdings Inc
10/04/202308:30GlobeNewswire Inc.Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023NASDAQ:ORGOOrganogenesis Holdings Inc
06/04/202310:31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ORGOOrganogenesis Holdings Inc
27/03/202309:00GlobeNewswire Inc.Organogenesis Applauds Findings from the Office of Inspector GeneralNASDAQ:ORGOOrganogenesis Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ORGO

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BOBR4
BOMBRIL PN
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
BOV
RENT3
LOCALIZA ON
BOV
VVEO3
CM Hospitalar ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados